2.87
-0.17(-5.59%)
Currency In USD
| Previous Close | 3.04 |
| Open | 3.03 |
| Day High | 3.03 |
| Day Low | 2.8 |
| 52-Week High | 3.94 |
| 52-Week Low | 0.69 |
| Volume | 6.15M |
| Average Volume | 6.66M |
| Market Cap | 578.44M |
| PE | -5.31 |
| EPS | -0.54 |
| Moving Average 50 Days | 2.62 |
| Moving Average 200 Days | 1.7 |
| Change | -0.17 |
If you invested $1000 in Esperion Therapeutics, Inc. (ESPR) 10 years ago, it would be worth $119.58 as of October 30, 2025 at a share price of $2.87. Whereas If you bought $1000 worth of Esperion Therapeutics, Inc. (ESPR) shares 5 years ago, it would be worth $95.76 as of October 30, 2025 at a share price of $2.87.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Esperion to Host Virtual Investor Key Opinion Leader Event Highlighting Significant Unmet Need in Statin Intolerance on Tuesday, November 11, 2025, at 2:00 p.m. ET.
GlobeNewswire Inc.
Oct 28, 2025 12:00 PM GMT
– Leading Cardiovascular Physician Experts to Explore Real-World Challenges and Impact on Patient Outcomes – ANN ARBOR, Mich., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it will host a virtual key opinion leader (KOL)
Esperion Announces New Analyses from CLEAR Outcomes to be Presented at the American Heart Association (AHA) Scientific Sessions 2025
GlobeNewswire Inc.
Oct 27, 2025 12:00 PM GMT
ANN ARBOR, Mich., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that an oral presentation and a poster presentation have been accepted for presentation at the AHA Scientific Sessions 2025 in New Orleans, LA, November 7-1
Esperion to Report Third Quarter 2025 Financial Results on November 6
GlobeNewswire Inc.
Oct 23, 2025 12:00 PM GMT
ANN ARBOR, Mich., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it will report third quarter 2025 financial results before the market opens on Thursday, November 6, 2025. Following the release, management will host a web